Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

61 trials with published results (17%)

Research Maturity

191 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

23 terminated out of 363 trials

Success Rate

89.3%

+2.7% vs benchmark

Late-Stage Pipeline

24%

86 trials in Phase 3/4

Results Transparency

32%

61 of 191 completed with results

Key Signals

61 with results89% success23 terminated

Data Visualizations

Phase Distribution

291Total
Not Applicable (143)
Early P 1 (5)
P 1 (25)
P 2 (32)
P 3 (46)
P 4 (40)

Trial Status

Completed191
Recruiting47
Unknown47
Not Yet Recruiting27
Terminated23
Withdrawn13

Trial Success Rate

89.3%

Benchmark: 86.5%

Based on 191 completed trials

Clinical Trials (363)

Showing 20 of 20 trials
NCT04131907Not ApplicableActive Not RecruitingPrimary

Optilume™ BPH Catheter System in Men With Symptomatic BPH

NCT04879940Phase 2Active Not Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

NCT07736807Not ApplicableNot Yet RecruitingPrimary

Early Electroacupuncture for Post-TURP LUTS

NCT07734233Not ApplicableCompletedPrimary

Spinal Versus General Anesthesia on Coagulation and Fibrinolysis During Transurethral Resection of the Prostate

NCT07103278Phase 1CompletedPrimary

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

NCT07722871Phase 1Not Yet RecruitingPrimary

A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

NCT06589154Completed

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

NCT07722884Not ApplicableRecruiting

Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH

NCT07569874Not ApplicableNot Yet RecruitingPrimary

Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia

NCT07715448Phase 4CompletedPrimary

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

NCT07694752Recruiting

MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology

NCT07715305Phase 1Not Yet RecruitingPrimary

A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

NCT07619105Not Yet RecruitingPrimary

A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate)

NCT07699718Not Yet RecruitingPrimary

Selective Median Lobe Surgery Outcomes Study

NCT06511141Not ApplicableRecruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT07698028Not ApplicableActive Not Recruiting

ExMI vs. Biofeedback PFMT for Post-Prostatectomy Incontinence

NCT06312722Not ApplicableRecruitingPrimary

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

NCT06560476Active Not RecruitingPrimary

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

NCT07663097Not Yet RecruitingPrimary

Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

NCT06965582Not ApplicableEnrolling By InvitationPrimary

A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System

Scroll to load more

Research Network

Activity Timeline